Status:
COMPLETED
Remicade Safety Line (Ankylosing Spondylitis)(Study P03275)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Collaborating Sponsors:
Centocor, Inc.
Conditions:
Spondylitis, Ankylosing
Eligibility:
All Genders
18+ years
Brief Summary
This observational study is in line with the German educational plan with the aim to implement a tool to increase and monitor the awareness of tuberculosis screening and to reinforce the patient eligi...
Detailed Description
This study population was chosen from a non-probability sample.
Eligibility Criteria
Inclusion
- Subjects with ankylosing spondylitis.
Exclusion
- As per Summary of Product Characteristics (SmPC)
Key Trial Info
Start Date :
July 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT00818168
Start Date
July 1 2003
End Date
December 1 2010
Last Update
September 3 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.